Inventor · disambiguated record
Stefan Heitmeier
Also filed as: HEITMEIER STEFAN
29 granted patents·28 pending applications·107 citations·filing 2003–2025
95Inventor score
Top patents by PatentIndex Score
57 records- 0189US9822102B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2016·Granted Nov 21, 2017·7 cites·7 claims
- 0289US8334291B2Aliphatically substituted pyrazolopyridines, and the use thereofSCHIROK HARTMUT·Filed 2009·Granted Dec 18, 2012·17 cites·5 claims
- 0388US9434690B2Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBayer Pharma AG·Filed 2014·Granted Sep 6, 2016·10 cites·8 claims
- 0487US10183932B2Substituted oxopyridine derivatives and use thereof cardiovascular disordersBayer Pharma AG·Filed 2017·Granted Jan 22, 2019·5 cites·8 claims
- 0586US10077265B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 18, 2018·4 cites·14 claims
- 0685US10421742B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2016·Granted Sep 24, 2019·3 cites·9 claims
- 0784US9475809B2Substituted oxopyridine derivatives and use thereof as factor xia/plasmaBayer Pharma AG·Filed 2014·Granted Oct 25, 2016·6 cites·7 claims
- 0884US9434731B2Imidazo-, pyrazolopyrazines and imidazotriazines and their useBAYER IP GMBH·Filed 2013·Granted Sep 6, 2016·8 cites·3 claims
- 0984US8273752B2Substituted imidazopyrimidines and triazolopyrimidinesSIEGEL STEPHAN·Filed 2008·Granted Sep 25, 2012·11 cites·5 claims
- 1083US8969045B2Method for detecting pyrophosphate by means of bioluminescence detectionBURKHARDT NILS·Filed 2007·Granted Mar 3, 2015·8 cites·11 claims
- 1182US10071995B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 11, 2018·3 cites·15 claims
- 1281US10138236B2Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivativesBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·15 claims
- 1379US9765070B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·4 cites·9 claims
- 1479US8198267B2Substituted oxazolidinones and their useALLERHEILIGEN SWEN·Filed 2008·Granted Jun 12, 2012·7 cites·8 claims
- 1578US10167280B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Jan 1, 2019·2 cites·16 claims
- 1678US9918969B2Substituted oxopyridine derivatives and use thereof as factor XIa/plasmaBayer Pharma AG·Filed 2016·Granted Mar 20, 2018·2 cites·3 claims
- 1777US12215168B2Anti-A2AP antibodies and uses thereofBAYER AG·Filed 2023·Granted Feb 4, 2025·0 cites·15 claims
- 1877US2025282748A1Substituted oxopyridine derivativesBayer Pharma AG·Filed 2025·Application pending·0 cites
- 1975US8987256B2Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereofHAHN MICHAEL·Filed 2009·Granted Mar 24, 2015·2 cites·10 claims
- 2074US11912692B2Substituted S-alaninate derivativesBAYER AG·Filed 2023·Granted Feb 27, 2024·0 cites·17 claims
- 2174US2025051303A1Substituted oxopyridine derivatives for the treatment and/or prophylaxis of thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complicationsBAYER AG·Filed 2024·Application pending·0 cites
- 2273US10414731B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2015·Granted Sep 17, 2019·1 cites·6 claims
- 2371US8383822B2Substituted oxazolidinones and their useBAYER IP GMBH·Filed 2008·Granted Feb 26, 2013·1 cites·11 claims
- 2471US2023024752A1Substituted oxopyridine derivativesBayer Pharma AG·Filed 2021·Application pending·0 cites
- 2571US2024034810A1Anti-a2ap antibodies and uses thereofBAYER AG·Filed 2023·Application pending·0 cites
- 2670US8642592B2Oxo-heterocyclically substituted alkyl carboxylic acids and use thereofLAMPE THOMAS·Filed 2010·Granted Feb 4, 2014·2 cites·10 claims
- 2767US11180471B2Substituted oxopyridine derivativesBayer Pharma AG·Filed 2019·Granted Nov 23, 2021·0 cites·67 claims
- 2866US2022306602A1Substituted oxopyridine derivatives for the treatment and/or prophylaxis of thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complicationsBAYER AG·Filed 2019·Application pending·0 cites
- 2963US2024010750A1Novel anti-a2ap antibodies and uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 3063US2025002483A1Substituted s-alaninate derivativesBAYER AG·Filed 2022·Application pending·0 cites
- 3159US2025302837A1Inhibitors of chymase for use in the selective resolution of thrombi in thrombotic or thromboembolic disordersSOCPRA SCIENCES SANTE ET HUMAINES S E C·Filed 2023·Application pending·0 cites
- 3255US8476267B2Imidazo-, pyrazolopyrazines and imidazotriazines and their useSIEGEL STEPHAN·Filed 2008·Granted Jul 2, 2013·0 cites·7 claims
- 3353US8487111B2Substituted oxazolidinones and their useALLERHEILIGEN SWEN·Filed 2008·Granted Jul 16, 2013·0 cites·8 claims
- 3450US2016010143A1Method for detecting pyrophosphate by means of bioluminescence detectionBAYER IP GMBH·Filed 2015·Application pending·0 cites
- 3550US2010004235A1Heterocyclic Substituted, Anellated Pyrazole Derivative and its usesBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 3649US8846934B2Substituted oxazolidinones and their useBAYER IP GMBH·Filed 2013·Granted Sep 30, 2014·0 cites·9 claims
- 3749US2011015241A1Substituted heterocycles and use thereofBAYER SCHERING PHARMA AG·Filed 2007·Application pending·0 cites
- 3849US2009258877A1Triazolotriazines and triazolopyrazines and their useBAYER HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 3947US9051323B2Substituted imidazopyrimidines and triazolopyrimidinesSIEGEL STEPHAN·Filed 2012·Granted Jun 9, 2015·0 cites·6 claims
- 4047US2010105663A12-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitorsBAYER HEALTHCARE AG·Filed 2007·Application pending·0 cites
- 4145US9493472B2Substituted benzoxazolesBayer Pharma AG·Filed 2014·Granted Nov 15, 2016·0 cites·17 claims
- 4245US2016222056A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4345US2016280688A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4445US2016237067A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4545US2016237045A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4645US2022144848A1Substituted oxopyridine derivativesBAYER AG·Filed 2019·Application pending·0 cites
- 4745US2016244437A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4845US2016280699A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 4945US2006078498A1Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192BAYER PHARMACEUTICALS CORPORAT·Filed 2003·Application pending·0 cites
- 5045US2016237044A1Substituted phenylalanine derivativesBayer Pharma AG·Filed 2014·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stefan Heitmeier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →